NamasteMD Signs Patient Services Agreement with

Vancouver, British Columbia, Canada – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company’s wholly-owned subsidiary, NamasteMD Inc. (“NamasteMD”), has signed a Patient Services Agreement (the “Agreement”) with (“Buds2go”). Buds2go is an online platform which holds over 80,000 users in its database with over 100,000 weekly sessions. Subject to the terms of the Agreement, Buds2go will offer users access to medical cannabis consultations through the Company’s wholly owned subsidiary and online patient portal, NamasteMD Inc. (“NamsteMD”).

The Company expects to see a significant increase in patient acquisition through NamasteMD, as Buds2go not only maintains a large database of users but also has very strong organic search traffic rankings. By leveraging NamasteMD’s platform, Buds2go is able to offer users with access to a simple and convenient platform to access medical cannabis consultations with a trained professional. While the Company is focused on the rapid expansion of its patient database through NamasteMD and in on-boarding new patients the Company is also actively focused on expanding its offering and securing a strong supply chain for the future.

NamasteMD’s innovative platform serves as a valuable resource for online sites to offer access to medical consultations and the ability to access medical cannabis through regulated channels. Management Commentary

Sean Dollinger, President, and CEO of Namaste comments: “We’re very pleased to announce the Agreement with Buds2go. We anticipate that their users will be happy to have access to medical cannabis consultations so that they have the ability to order medical cannabis online through a licensed producer. Buds2go maintains a large database of users and is one of the highest-ranked e-commerce sites targeting keywords related to many popular cannabis strains. We’re looking forward to seeing positive results. We believe that NamasteMD offers itself as a powerful resource that provides users with access to order medical cannabis products through the regulated market.

About Namaste Technologies Inc. Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with over 30 websites in 20+ countries under various brands. Namaste’s product offering through its subsidiaries includes vaporizers, glassware, accessories, CBD products, and medical cannabis in the Canadian market.

Namaste has developed and acquired innovative technology platforms including, and in May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB. Findify uses artificial intelligence algorithms to optimize and personalize a consumer’s on-site buying experience. Namaste is focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors “Sean Dollinger” Chief Executive Officer Direct: +1 604-355-6100 Email: [email protected] Further information on the Company and its products can be accessed through the links below:

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press release.